The latest coronavirus developments and scientific research on prevention and treatment.
Two doses of mRNA covid-19 vaccine during pregnancy show significant efficacy against delta and omicron infection in infants under six-months old. They also reduce hospital admission for covid-19… read more.
Professor Colleen Aldous is a research professor at in the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial… read more.
Colleen Aldous, Professor for Medical Research, University of KwaZulu-Natal explains how the evidence supporting the use of ivermectin for covid-19 came together to tell a compelling story. In… read more.
A new study, published in the European Journal of Public Health based on data from 25,049 children aged three to five, shows an increase in obesity during the COVID-19… read more.
When assessing repurposed drugs in a pandemic situation, the totality of evidence should be considered rather than RCTs alone; had this been done the pandemic could have been… read more.
The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction… read more.
The best time to administer ivermectin is at the beginning of a covid-19 infection so that virus is killed and disease progression averted, according to Colleen Aldous, Professor… read more.
Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of… read more.
For frontline healthcare workers, the mental health impact from the pandemic is extending beyond career burnout. Much of the attention on the mental toll suffered by frontline workers… read more.
Nearly half a million people missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to research supported by the British Heart Foundation… read more.
Most symptoms or conditions that develop after mild covid-19 infection linger for several months but return to normal within a year, finds a large study from Israel published… read more.
Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
